News und Analysen
Humana Announces Major Tennessee Expansion, Will Sell Medicare Advantage Plans in 31 More Counties
As part of Humana Inc.’s (NYSE: HUM) major Tennessee expansion in 2021, the leading health and well-being company announced today it is introducing a new Medicare Advantage Health Maintenance
Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses
Waters Corporation (NYSE:WAT) today introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology. The columns are
Agilent Early Career Professor Award Presented to Carl DeSelm
Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is an assistant professor of Radiation
Humana Welcomes Additional Retail Pharmacies to Preferred Medicare Part D Network
Humana Inc. (NYSE: HUM), a leading health and well-being company, has announced that Kroger Health and its family of pharmacies, Costco, Publix and HEB have joined its preferred stand-alone
Humana, Humana Foundation Commit More Than $1 Million to COVID-19 Relief and Recovery Efforts in Georgia
Together, Humana Inc. (NYSE: HUM) and the company’s philanthropic arm, The Humana Foundation, have committed more than $1 million in COVID-19 relief for communities in Georgia to date.
“The
CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020
The table in the release was incorrect. The corrected table should read:
PerkinElmer, Inc:
PerkinElmer, Inc. and SubsidiariesRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint
The German Breast Group (GBG) and Pfizer Inc. (NYSE: PFE) today announced that the collaborative Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free
Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases
Agilent Technologies Inc. (NYSE: A) today announced the expansion of Visiopharm’s validated image analysis algorithm to incorporate HercepTest™ mAb pharmDx for Dako Omnis, both CE-IVD marked and
Humana Expanding in New Jersey, Will Sell Medicare Advantage Plans in Four More Counties
Leading health and well-being company Humana Inc. (NYSE: HUM) announced today it will grow its New Jersey market footprint by offering Medicare Advantage plans in four additional counties in the
Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in
Alexion Pharma: Völlig egal, ob der Mega-Merger kommt!
Zu den Topgewinnern an den US-Aktienmärkten zählt heute die Aktie des Biopharmakonzerns Alexion Pharmaceutical (WKN: 899527). Da stellt sich natürlich die Frage nach dem Warum?
Schließlich
Humana Medicare Advantage Members Benefit From Improved Health Outcomes, Preventive Care and an Estimated $4 Billion in Reduced Costs Through Value-Based Care
Humana Inc. (NYSE: HUM) unveiled today its annual Value-based Care Report, detailing that 2.41 million Humana individual Medicare Advantage beneficiaries receiving care from primary care physicians
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of
Centura Health and Humana Sign Agreement, Expanding Humana’s Medicare Advantage Provider Network in Colorado Springs
Centura Health and Humana Inc. (NYSE: HUM), a leading health and well-being company, have signed an in-network agreement in Colorado Springs, expanding access to care for Humana Medicare members.
Grand View Health and Humana Sign Medicare Network Agreement in Pennsylvania
Community health system Grand View Health and leading health and well-being company Humana Inc. (NYSE: HUM) have signed an agreement that will provide in-network access for Humana Medicare
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or
Humana Rolls Out 2021 Medicare Advantage Health Plans with Expanded $0 Premiums and Enhanced Benefits in More Counties Nationwide
Humana Inc. (NYSE: HUM) today announced details of its 2021 Medicare product offerings, including Medicare Advantage and Prescription Drug Plans that are built with the benefits and options people
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy
Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from
University of Toledo Medical Center, University of Toledo Physicians Sign Network Agreements with Humana
Leading health and well-being company Humana Inc. (NYSE: HUM) announced today it has signed Medicare and commercial plan network agreements with University of Toledo Medical Center (UTMC) and
Rush Health and Humana Sign Medicare Network Agreement
Clinically-integrated physician and hospital network Rush Health and leading health and well-being company Humana Inc. (NYSE: HUM) today announced an agreement to expand access to quality
U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) for the treatment of children and adolescents 2 years and
Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the third quarter 2020 following the close of market on Thursday, October 29, 2020.
On the same day, at 2:00 pm Pacific
The Ohio State University Wexner Medical Center and Humana Announce Medicare Network Agreement
The Ohio State University Wexner Medical Center and Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, have signed an agreement to expand access to in-network
Pfizer Declares Fourth-Quarter 2020 Dividend
The board of directors of Pfizer Inc. (NYSE:PFE) declared a 38-cent fourth-quarter 2020 dividend on the company’s common stock, payable December 1, 2020, to holders of the Common Stock of record at
Illumina to Webcast Upcoming Investor Conference Presentation
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
Cowen’s Liquid Biopsy